Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells

European Journal of Immunology

Volumn 32, Issue 2, 2002, Pages 374-382

  Hunziker, Lukas ^a   Klenerman, Paul ^a,c   Zinkernagel, Rolf M ^a   Ehl, Stephan ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HYPERIMMUNE GLOBULIN; MUTANT PROTEIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CELL KINETICS; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE CARRIER; DISEASE MODEL; DONOR; HELPER CELL; LYMPHOCYTE TRANSFER; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; T LYMPHOCYTE; VIRUS CARRIER; VIRUS LOAD; VIRUS MENINGITIS;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 0036180057     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200202)32:2<374::AID-IMMU374>3.0.CO;2-9     Document Type: Article

References (60)

1. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones
2. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T cell clones from the donor
3. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation
4. Adoptive cellular immunotherapy for EBV lymphoproliferative disease
5. + T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS
6. Vivo migration and function of transferred HIV-1-specific cytotoxic T cells
7. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death
8. Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses
9. + lymphocytes
10. + CTL clones is limited by elimination due to encounter with HIV-infected targets
11. Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome
12. The virology and immunobiology of lymphocytic choriomeningitis virus infection
13. Immune therapy of a persistent and disseminated viral infection
14. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system
15. Studies on immunological tolerance to LCM virus. 2. Treatment of virus carriers by adoptive immunization
16. Studies on immunological tolerance to LCM virus. The question of immunity in adoptively immunized virus carriers
17. An essential role for type 1 interferon-gamma in terminating persistent viral infection
18. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers
19. + T cells
20. T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice
21. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
22. + T cells upon acute versus persistent viral infection
23. + T cell-deficient mice
24. + cytotoxic T cell responses during chronic viral infection
25. The X-Y-Z scheme of immunocyte maturation. IV. The exhaustion of memory cells
26. 51chromium
27. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
28. Peripheral selection of the T cell repertoire
29. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance
30. Viral immune evasion due to persistence of activated T cells without effector function
31. + T cell responses associated with control of viremia
32. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge
33. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
34. + T cells in vivo by IL-15
35. + memory T cells by opposing cytokines
36. + T cell memory by short-term IL-4 exposure during T cell receptor stimulation
37. Help for cytotoxic-T cell responses is mediated by CD40 signalling
38. T cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
39. + T- helper and a T-killer cell
40. Differential requirements for survival and proliferation of CD8 naive or memory T cells
41. Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells
42. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera
43. Vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody
44. Control of early viral and bacterial distribution and disease by natural antibodies
45. Reciprocal regulation of polarized cytokine production by effector B and T cells
46. The fate of adoptively transferred antigen-specific T cells in vivo
47. + T cells to cause immunopathology
48. T cell priming versus T cell tolerance induced by synthetic peptides
49. Chronic intravenous injections of antigen induce and maintain tolerance in T cell receptor-transgenic mice
50. The duration of antigenic stimulation determines the fate of naive and effector T cells
51. + T cells
52. + T cell clones during primary HIV infection
53. Effector T cell induction and T cell memory versus peripheral deletion of T cells
54. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection
55. The impact of variation in the number of CD8(+)T cell precursors on the outcome of virus infection
56. + T cells. Correction
57. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates
58. + memory T cells in virus-infected hosts
59. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo
60. T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I- restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?